المؤلفون: Kulasekararaj, Austin G., Lehtinen, Anna-Elina, Forsyth, Cecily, Gandhi, Shreyans, Griffin, Morag, Körper, Sixten, Mikala, Gabor, Muus, Petra, Overgaard, Ulrik, Patriquin, Christopher J., Pullon, Humphrey, Shen, Yu Min, Spearing, Ruth, Szer, Jeff, de la Borderie, Guillemette, Duda, Petra W., Farzaneh-Far, Ramin, Ragunathan, Sharan, Sayegh, Camil E., Vadysirisack, Douangsone D., Schrezenmeier, Hubert

المساهمون: HUS Comprehensive Cancer Center, Department of Oncology

مصطلحات موضوعية: 3122 Cancers

وصف الملف: application/pdf

العلاقة: The authors would like to acknowledge the following contributors: Stephen Babcock, MS, of UCB Pharma, for support as Clinical Project Manager for the studies; Anita Hill, MD, PhD, formerly of the National Health Service, UK, for work as a study investigator; and Veronica Porkess, PhD, CMPP, of UCB Pharma, for publication and editorial support. Studies 201, 202, and 203 were funded by Ra Pharmaceuticals (Cambridge, MA, USA; now a part of UCB Pharma [Brussels, Belgium]). Medical writing and editorial assistance were provided by Jessica Deckman, PhD, CMPP, of The Lockwood Group (Stamford, CT, USA), and funded by UCB Pharma, in accordance with Good Publications Practice (GPP) 2022 guidelines; Kulasekararaj , A G , Lehtinen , A-E , Forsyth , C , Gandhi , S , Griffin , M , Körper , S , Mikala , G , Muus , P , Overgaard , U , Patriquin , C J , Pullon , H , Shen , Y M , Spearing , R , Szer , J , de la Borderie , G , Duda , P W , Farzaneh-Far , R , Ragunathan , S , Sayegh , C E , Vadysirisack , D D & Schrezenmeier , H 2024 , ' Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria ' , Haematologica , vol. 109 , no. 3 , pp. 929-935 . https://doi.org/10.3324/haematol.2022.281780Test; http://hdl.handle.net/10138/574635Test; 45b8690e-0ad1-4be0-9aae-4c1cee4ac87e; 85186744903; 001182209400033

الإتاحة: http://hdl.handle.net/10138/574635Test

المؤلفون: Tang, Guo-Qing, Tang, Yalan, Dhamnaskar, Ketki, Hoarty, Michelle D., Vyasamneni, Rohit, Vadysirisack, Douangsone D., Ma, Zhong, Zhu, Nanqun, Wang, Jian-Guo, Bu, Charlie, Cong, Bestine, Palmer, Elizabeth, Duda, Petra W., Sayegh, Camil, Ricardo, Alonso

المساهمون: UCB Pharma

المصدر: Frontiers in Immunology ; volume 14 ; ISSN 1664-3224

الإتاحة: https://doi.org/10.3389/fimmu.2023.1213920Test

المؤلفون: Tang, Guo-Qing, Tang, Yalan, Dhamnaskar, Ketki, Hoarty, Michelle D., Vyasamneni, Rohit, Vadysirisack, Douangsone D., Ma, Zhong, Zhu, Nanqun, Wang, Jian-Guo, Bu, Charlie, Cong, Bestine, Palmer, Elizabeth, Duda, Petra W., Sayegh, Camil, Ricardo, Alonso

المصدر: Frontiers in Immunology ; volume 14 ; ISSN 1664-3224

مصطلحات موضوعية: Immunology, Immunology and Allergy

الإتاحة: https://doi.org/10.3389/fimmu.2023.1282155Test

المؤلفون: Vadysirisack, Douangsone D.

مصطلحات موضوعية: Biology, Molecular

الإتاحة: http://rave.ohiolink.edu/etdc/view?acc_num=osu1196114692Test

المؤلفون: Fichtner, Miriam L., Hoarty, Michelle D., Vadysirisack, Douangsone D., Munro-Sheldon, Bailey, Nowak, Richard J., O’Connor, Kevin C.

المساهمون: Saruhan-Direskeneli, Güher, UCB US, Myasthenia Gravis Foundation of America, National Institute of Allergy and Infectious Diseases, Muscular Dystrophy Association, Grifols, Deutsche Forschungsgemeinschaft

المصدر: PLOS ONE ; volume 17, issue 3, page e0264489 ; ISSN 1932-6203

الإتاحة: https://doi.org/10.1371/journal.pone.0264489Test

المؤلفون: Muldur, Sinan, Vadysirisack, Douangsone D., Ragunathan, Sharan, Tang, Yalan, Ricardo, Alonso, Sayegh, Camil Elie, Irimia, Daniel

المساهمون: National Institutes of Health

المصدر: Frontiers in Immunology ; volume 12 ; ISSN 1664-3224

مصطلحات موضوعية: Immunology, Immunology and Allergy

الإتاحة: https://doi.org/10.3389/fimmu.2021.777932Test

المؤلفون: Guo-Qing Tang, Yalan Tang, Dhamnaskar, Ketki, Hoarty, Michelle D., Vyasamneni, Rohit, Vadysirisack, Douangsone D., Zhong Ma, Nanqun Zhu, Jian-Guo Wang, Bu, Charlie, Cong, Bestine, Palmer, Elizabeth, Duda, Petra W., Sayegh, Camil, Ricardo, Alonso

المصدر: Frontiers in Immunology; 2023, p1-11, 11p

مصطلحات موضوعية: ECULIZUMAB, COMPLEMENT (Immunology), COMPLEMENT activation, PEPTIDES, COMPLEMENT inhibition, SURFACE plasmon resonance

المؤلفون: Chryssa Zografou, William M. Philbrick, Vadysirisack Douangsone D, Kevin C. O’Connor, Richard Nowak, Jeffrey Bennett, Abeer H. Obaid, Miriam L. Fichtner, Bailey Munro-Sheldon

المصدر: Neurol Neuroimmunol Neuroinflamm

مصطلحات موضوعية: CD46, Chemistry, Autoantibody, Correction, CD59, medicine.disease, Myasthenia gravis, Acetylcholine binding, Complement inhibitor, HEK293 Cells, Neurology, Immunology, Myasthenia Gravis, medicine, Humans, Receptors, Cholinergic, Neurology (clinical), Complement membrane attack complex, Complement Activation, Acetylcholine receptor, Autoantibodies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04a2cf9c3b960ef25c0f911b089ed79cTest
https://europepmc.org/articles/PMC9352342Test/

المؤلفون: Obaid, Abeer H., Zografou, Chryssa, Vadysirisack, Douangsone D., Munro-Sheldon, Bailey, Fichtner, Miriam L., Roy, Bhaskar, Philbrick, William M., Bennett, Jeffrey L., Nowak, Richard J., O'Connor, Kevin C.

المصدر: Neurology Neuroimmunology & Neuroinflammation ; volume 9, issue 4 ; ISSN 2332-7812

الإتاحة: https://doi.org/10.1212/nxi.0000000000001169Test

المؤلفون: Horak, Peter, Crawford, Andrew R., Vadysirisack, Douangsone D., Nash, Zachary M., DeYoung, M. Phillip, Sgroi, Dennis, Ellisen, Leif W., Semenza, Gregg L.

المصدر: Proceedings of the National Academy of Sciences of the United States of America, 2010 Mar 01. 107(10), 4675-4680.

الوصول الحر: https://www.jstor.org/stable/25664857Test